This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

METFORMIN HYDROCHLORIDE

Read time: 1 mins
Marketing start date: 14 Nov 2024

Summary of product characteristics


Effective Time

20221105

Version

2

Spl Product Data Elements

METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE METFORMIN GLYCERYL BEHENATE/EICOSADIOATE HYPROMELLOSES POVIDONE CELLULOSE, MICROCRYSTALLINE WHITE TO OFF-WHITE CAPSULE 63;Z METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE METFORMIN GLYCERYL DIBEHENATE HYPROMELLOSES POVIDONE CELLULOSE, MICROCRYSTALLINE WHITE TO OFF-WHITE CAPSULE Z;C;20

Application Number

ANDA077060

Brand Name

METFORMIN HYDROCHLORIDE

Generic Name

METFORMIN HYDROCHLORIDE

Product Ndc

65841-027

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-027-05 in bottle of 500 tablets Metformin Hydrochloride Extended-release Tablets USP, 500 mg Rx only 500 tablets NDC 65841-039-05 in bottle of 500 tablets Metformin Hydrochloride Extended-release Tablets USP, 750 mg Rx only 500 tablets 500 mg 750 mg

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.